Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Treatments: Glycine; Sivelestat

Criteria

Inclusion Criteria:

• Patients with community-acquired pneumonia

• Patients with acute respiratory failure

Exclusion Criteria:

• Patients with nosocomial pneumonia

• Patients on mechanical ventilation